Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Microbiological and immunological characteristics of a lethal pulmonary Aspergillus niger infection in a non-neutropenic patient.

Workum JD, de Jong SW, Gresnigt MS, Becker KL, Pickkers P, van de Veerdonk FL, Heijdra YF, Kolwijck E.

Med Mycol Case Rep. 2018 Mar 7;21:4-7. doi: 10.1016/j.mmcr.2018.03.002. eCollection 2018 Sep.

2.

Effect of Presymptomatic Body Mass Index and Consumption of Fat and Alcohol on Amyotrophic Lateral Sclerosis.

Huisman MH, Seelen M, van Doormaal PT, de Jong SW, de Vries JH, van der Kooi AJ, de Visser M, Schelhaas HJ, van den Berg LH, Veldink JH.

JAMA Neurol. 2015 Oct;72(10):1155-62. doi: 10.1001/jamaneurol.2015.1584.

PMID:
26280944
3.

Prior medical conditions and the risk of amyotrophic lateral sclerosis.

Seelen M, van Doormaal PT, Visser AE, Huisman MH, Roozekrans MH, de Jong SW, van der Kooi AJ, de Visser M, Voermans NC, Veldink JH, van den Berg LH.

J Neurol. 2014 Oct;261(10):1949-56. doi: 10.1007/s00415-014-7445-1. Epub 2014 Jul 25.

PMID:
25059395
4.

Lifetime physical activity and the risk of amyotrophic lateral sclerosis.

Huisman MH, Seelen M, de Jong SW, Dorresteijn KR, van Doormaal PT, van der Kooi AJ, de Visser M, Schelhaas HJ, van den Berg LH, Veldink JH.

J Neurol Neurosurg Psychiatry. 2013 Sep;84(9):976-81. doi: 10.1136/jnnp-2012-304724. Epub 2013 Feb 16.

PMID:
23418211
5.

Parental age and the risk of amyotrophic lateral sclerosis.

de Jong SW, Huisman MH, Hennekam EA, Sutedja NA, van der Kooi AJ, de Visser M, Schelhaas HJ, Fischer K, Veldink JH, van den Berg LH.

Amyotroph Lateral Scler Frontotemporal Degener. 2013 Apr;14(3):224-7. doi: 10.3109/21678421.2012.739176. Epub 2012 Nov 14.

PMID:
23151261
6.

Smoking, alcohol consumption, and the risk of amyotrophic lateral sclerosis: a population-based study.

de Jong SW, Huisman MH, Sutedja NA, van der Kooi AJ, de Visser M, Schelhaas HJ, Fischer K, Veldink JH, van den Berg LH.

Am J Epidemiol. 2012 Aug 1;176(3):233-9. doi: 10.1093/aje/kws015. Epub 2012 Jul 11.

PMID:
22791740
7.

Family history of neurodegenerative and vascular diseases in ALS: a population-based study.

Huisman MH, de Jong SW, Verwijs MC, Schelhaas HJ, van der Kooi AJ, de Visser M, Veldink JH, van den Berg LH.

Neurology. 2011 Oct 4;77(14):1363-9. doi: 10.1212/WNL.0b013e318231530b. Epub 2011 Sep 21.

PMID:
21940614
8.

Population based epidemiology of amyotrophic lateral sclerosis using capture-recapture methodology.

Huisman MH, de Jong SW, van Doormaal PT, Weinreich SS, Schelhaas HJ, van der Kooi AJ, de Visser M, Veldink JH, van den Berg LH.

J Neurol Neurosurg Psychiatry. 2011 Oct;82(10):1165-70. doi: 10.1136/jnnp.2011.244939. Epub 2011 May 27.

PMID:
21622937
9.

Randomized sequential trial of valproic acid in amyotrophic lateral sclerosis.

Piepers S, Veldink JH, de Jong SW, van der Tweel I, van der Pol WL, Uijtendaal EV, Schelhaas HJ, Scheffer H, de Visser M, de Jong JM, Wokke JH, Groeneveld GJ, van den Berg LH.

Ann Neurol. 2009 Aug;66(2):227-34. doi: 10.1002/ana.21620.

PMID:
19743466
10.

Genetic variation in DPP6 is associated with susceptibility to amyotrophic lateral sclerosis.

van Es MA, van Vught PW, Blauw HM, Franke L, Saris CG, Van den Bosch L, de Jong SW, de Jong V, Baas F, van't Slot R, Lemmens R, Schelhaas HJ, Birve A, Sleegers K, Van Broeckhoven C, Schymick JC, Traynor BJ, Wokke JH, Wijmenga C, Robberecht W, Andersen PM, Veldink JH, Ophoff RA, van den Berg LH.

Nat Genet. 2008 Jan;40(1):29-31. Epub 2007 Dec 16.

PMID:
18084291
11.

ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association study.

van Es MA, Van Vught PW, Blauw HM, Franke L, Saris CG, Andersen PM, Van Den Bosch L, de Jong SW, van 't Slot R, Birve A, Lemmens R, de Jong V, Baas F, Schelhaas HJ, Sleegers K, Van Broeckhoven C, Wokke JH, Wijmenga C, Robberecht W, Veldink JH, Ophoff RA, van den Berg LH.

Lancet Neurol. 2007 Oct;6(10):869-77.

PMID:
17827064

Supplemental Content

Loading ...
Support Center